Study identifier:D1690R00002
ClinicalTrials.gov identifier:NCT02322762
EudraCT identifier:N/A
CTIS identifier:N/A
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings
Type 2 Diabetes Mellitus
N/A
No
-
All
15992
Observational
18 Years +
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jun 2022 by AstraZeneca
AstraZeneca
Not Applicable
No locations available
Arms | Assigned Interventions |
---|---|
One single cohort. One single cohort of patients with type 2 diabetes mellitus initiating their second line anti-diabetic therapy after first line anti-diabetic therapy. | - |